Nephro-Urology Monthly

Published by: Kowsar

Diverse Clinical and Histology Presentation in C1q Nephropathy

Pavan Malleshappa 1 , * and Mahesha Vankalakunti 2
Authors Information
1 Division of Nephrology, Department of Medicine, Adichunchanagiri Institute of Medical Sciences, Mandya, India
2 Department of Nephro-pathology, Manipal Hospital, Bangalore, India
Article information
  • Nephro-Urology Monthly: July 01, 2013, 5 (3); 787-91
  • Published Online: June 25, 2013
  • Article Type: Review Article
  • Received: September 27, 2012
  • Revised: October 29, 2012
  • Accepted: November 11, 2012
  • DOI: 10.5812/numonthly.8308

To Cite: Malleshappa P, Vankalakunti M. Diverse Clinical and Histology Presentation in C1q Nephropathy, Nephro-Urol Mon. 2013 ; 5(3):787-91. doi: 10.5812/numonthly.8308.

Abstract
Copyright © 2013, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. C1q – Key Factor in Complement Activation and Source
3. Pathogenesis
4. Histologic Patterns of C1q Nephropathy
5. Clinical Presentation
6. Management and Response
7. Conclusion
Acknowledgements
Footnotes
References
  • 1. Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis. 1985; 6(2): 103-10[PubMed]
  • 2. Iskandar SS, Browning MC, Lorentz WB. C1q nephropathy: a pediatric clinicopathologic study. Am J Kidney Dis. 1991; 18(4): 459-65[PubMed]
  • 3. Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int. 2003; 64(4): 1232-40[DOI][PubMed]
  • 4. Burton DR, Gerald BA. C1q nephropathy. 2004;
  • 5. Berger SP, Roos A, Daha MR. Complement and the kidney: what the nephrologist needs to know in 2006? Nephrol Dial Transplant. 2005; 20(12): 2613-9[DOI][PubMed]
  • 6. Brown KM, Sacks SH, Sheerin NS. Mechanisms of disease: the complement system in renal injury--new ways of looking at an old foe. Nat Clin Pract Nephrol. 2007; 3(5): 277-86[DOI][PubMed]
  • 7. Walport MJ, Lachmann PJ. Clinical aspects of immunology. 1993; : 347-70
  • 8. van den Dobbelsteen ME, van der Woude FJ, Schroeijers WE, Klar-Mohamad N, van Es LA, Daha MR. Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells. J Am Soc Nephrol. 1996; 7(4): 573-81[PubMed]
  • 9. Thomas DB. Focal segmental glomerulosclerosis: a morphologic diagnosis in evolution. Arch Pathol Lab Med. 2009; 133(2): 217-23[DOI][PubMed]
  • 10. Isaac J, Shihab FS. De novo C1q nephropathy in the renal allograft of a kidney pancreas transplant recipient: BK virus-induced nephropathy? Nephron. 2002; 92(2): 431-6[PubMed]
  • 11. Lim IS, Yun KW, Moon KC, Cheong HI. Proteinuria in a boy with infectious mononucleosis, C1q nephropathy, and Dent's disease. J Korean Med Sci. 2007; 22(5): 928-31[PubMed]
  • 12. Mii A, Shimizu A, Masuda Y, Fujita E, Aki K, Ishizaki M, et al. Current status and issues of C1q nephropathy. Clin Exp Nephrol. 2009; 13(4): 263-74[DOI][PubMed]
  • 13. Vizjak A, Ferluga D, Rozic M, Hvala A, Lindic J, Levart TK, et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol. 2008; 19(11): 2237-44[DOI][PubMed]
  • 14. Srivastava T, Chadha V, Taboada EM, Alon US. C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis. Pediatr Nephrol. 2000; 14(10-11): 976-9[PubMed]
  • 15. Emanicipator SN. Renal Biopsy Inerpretation. 1996; : 147-180
  • 16. Ardalan MR, Sadreddini S, Nasri H. C1q Nephropathy in Association with Deforming arthritis. Nephro-Urol Mon. 2010; 2(2): 383-85
  • 17. Srivastava T, Chadha V. C1q nephropathy presenting as rapidly progressive crescentic glomerulonephritis. Clin Exp Nephrol. 2009; 13(4): 263-74
  • 18. Malleshappa P, Ranganath R, Chaudhari AP, Ayiangar A, Lohitaksha S. C1q nephropathy presenting as acute renal failure. Saudi J Kidney Dis Transpl. 2011; 22(2): 324-6[PubMed]
  • 19. Nishida M, Kawakatsu H, Komatsu H, Ishiwari K, Tamai M, Sawada T. Spontaneous improvement in a case of C1q nephropathy. Am J Kidney Dis. 2000; 35(5)[PubMed]
  • 20. Kersnik Levart T, Kenda RB, Avgustin Cavic M, Ferluga D, Hvala A, Vizjak A. C1Q nephropathy in children. Pediatr Nephrol. 2005; 20(12): 1756-61[DOI][PubMed]
  • 21. Hisano S, Fukuma Y, Segawa Y, Niimi K, Kaku Y, Hatae K, et al. Clinicopathologic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol. 2008; 3(6): 1637-43[DOI][PubMed]
  • 22. Sinha A, Nast CC, Hristea I, Vo AA, Jordan SC. Resolution of clinical and pathologic features of C1q nephropathy after rituximab therapy. Clin Exp Nephrol. 2011; 15(1): 164-70[DOI][PubMed]
  • 23. Said SM, Cornell LD, Valeri AM, Sethi S, Fidler ME, Cosio FG, et al. C1q deposition in the renal allograft: a report of 24 cases. Mod Pathol. 2010; 23(8): 1080-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments